This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Pre-Attached LTA Kit 4% Lidocaine Hydrochloride Topical Solution USP (2014-07-31)
- Starting date:
- July 31, 2014
- Posting date:
- August 12, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-41019
Recalled Products
Pre-Attached LTA Kit 4% Lidocaine Hydrochloride Topical Solution USP
Reason
Potential of the cannula breakage during insertion into patients’ airways.
Depth of distribution
Wholesalers and hospitals in Canada
Affected products
Pre-Attached LTA Kit 4% Lidocaine Hydrochloride Topical Solution USP
DIN, NPN, DIN-HIM
DIN 00295531
Dosage form
Plastic canula with attached vial injector and a single use vial
Strength
40 mg/ml
Lot or serial number
- 23303R1
- 36200R1
Companies
- Recalling Firm
-
Hospira Healthcare Corporation
1111 Dr. Frederik Philips Blvd.,
Saint-Laurent
H4M 2X6
Quebec
CANADA
- Marketing Authorization Holder
-
Hospira Healthcare Corporation
1111 Dr. Frederik Philips Blvd.,
Saint-Laurent
H4M 2X6
Quebec
CANADA